Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Does Cannabis Help Maintain Daily Routines in Dementia? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Maintaining daily routines is essential for people living with dementia, helping to support stability, independence, and emotional wellbeing. As interest in medical cannabis grows, researchers are asking whether compounds like THC and CBD might help regulate mood, motivation, and sleep, all of which influence a person’s ability to follow routines. While early evidence suggests potential benefits for agitation and sleep, there is no direct proof that cannabis helps maintain daily routines in dementia. 

Can medical cannabis be accessed legally for women’s health?

Why Routine Matters 

Consistent daily routines help people with dementia reduce confusion, anxiety, and agitation. Regular schedules also support healthy sleep patterns, appetite, and engagement in daily tasks. According to NHS dementia guidance, non-drug strategies such as structured activities, environmental stability, and caregiver support are the best ways to preserve daily functioning. 

How Cannabis Might Affect Routine 

Cannabis acts on the endocannabinoid system, which helps regulate mood, alertness, and circadian rhythm. 

  • THC binds to CB1 receptors in the brain, influencing energy, motivation, and sleep–wake balance. Low doses may promote relaxation and improve sleep, while higher doses can cause sedation or confusion. 
  • CBD interacts with serotonin (5-HT1A) and CB2 receptors, potentially helping to reduce anxiety and stabilise mood, which could indirectly support daily engagement. 

A 2023 study published in Frontiers in Aging Neuroscience (PubMed 36247984) found that balanced THC: CBD oils improved sleep quality and reduced evening agitation in dementia patients. Improved rest may help support more predictable daytime routines. Similarly, a 2024 review in Frontiers in Psychiatry (PubMed 38447959) suggested cannabinoids may help regulate the sleep–wake cycle, although data are still limited. 

What NICE And NHS Say 

The NICE dementia guideline (NG97) and NICE cannabis-based medicinal products guidance (NG144) do not recommend cannabis for improving daily function or routine maintenance in dementia. The Alzheimer’s Society UK notes that while cannabis may ease agitation or aid sleep, there is no clinical evidence that it supports daily structure or independence. 

Clinical Bottom Line 

  • THC: CBD oils may improve sleep and reduce agitation, indirectly supporting routine stability. 
  • CBD may reduce anxiety and promote calm, helping engagement in daily activities. 
  • No direct studies confirm cannabis improves or maintains routines in dementia. 
  • NICE and NHS recommend behavioural and environmental strategies instead. 

Educational Context: AlleviMed 

AlleviMed provides educational information about regulated cannabis-based medicinal products in the UK. It explains how these are prescribed under MHRA and Home Office frameworks but clarifies that cannabis is not licensed for supporting daily routines in dementia. 

Takeaway 

While cannabis compounds like THC and CBD may help with sleep and agitation, there is no evidence they help maintain daily routines in dementia. According to NHS and NICE, structured activities, consistent care, and supportive environments remain the best ways to promote stability and independence in dementia care. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories